Accessibility information | Access Keys

The Oncology Products Division conducts the marketing of Biocompatibles’ approved oncology products, supplied from facilities in Farnham, UK. These include Drug-Eluting Bead products which are used in more than 35 countries for the treatment of primary liver cancer (HCC), liver metastases from colorectal cancer, and other cancers. Our distribution partners include AngioDynamics Inc., Terumo Corporation and Eisai Co. Ltd.
English
FrançaisVoix hors-champ uniquement | Voix hors-champ plus texte sur écran
Español
DeutchNur Voice-over | Voice-over plus Textdarstellung auf dem Bildschirm
Italiano



Bead Block is an embolic device intended for the purpose of embolising the blood vessels of a variety of hypervascularised tumours and arteriovenous ..
DC Bead, a Drug-Eluting Bead, is a drug delivery embolisation system, intended to be loaded with a drug for the purpose of treating a variety of ..
LC Bead is a controlled embolisation system intended for the purpose of embolising the blood vessels of a variety of hypervascularised tumours ..
PRECISION Bead, a Drug-Eluting Bead, is a drug delivery embolisation system loaded with doxorubicin intended for the purpose of treating ..
Biocompatibles Drug-Eluting Bead technology is supported by a comprehensive programme of clinical trials designed to confirm our products'...
Browse a selection of peer review journal articles, abstracts, presentations and more.
Browse our Frequently Asked Questions. Answers are available as PDF files to download and keep



Sign up to receive email updates on the latest from biocompatibles.com
The products may not be available for sale, may not be registered, approved or cleared for use as claimed, in all countries where Biocompatibles is represented.
© 2010 Biocompatibles UK Ltd - All rights reserved - Site map - Terms & conditions - Accessiblity - Help - Glossary